Jung HA - Search Results

1

Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC).

Choi DH, Jung HA, Park S, Sun JM, Ahn JS, Ahn MJ, Lee SH. Choi DH, et al. Among authors: jung ha. Transl Lung Cancer Res. 2023 Dec 26;12(12):2448-2459. doi: 10.21037/tlcr-23-643. Epub 2023 Dec 22. Transl Lung Cancer Res. 2023. PMID: 38205202 Free PMC article.

2

High-throughput molecular genotyping for small biopsy samples in advanced non-small cell lung cancer patients.

Maeng CH, Lee HY, Kim YW, Choi MK, Hong JY, Jung HA, Lee KS, Kim H, Kwon OJ, Sun JM, Ahn JS, Park K, Um SW, Ahn MJ. Maeng CH, et al. Among authors: jung ha. Anticancer Res. 2013 Nov;33(11):5127-33. Anticancer Res. 2013. PMID: 24222160

3

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment.

Park YH, Jung HA, Choi MK, Chang W, Choi YL, Do IG, Ahn JS, Im YH. Park YH, et al. Among authors: jung ha. Br J Cancer. 2014 Jan 21;110(2):384-91. doi: 10.1038/bjc.2013.757. Epub 2013 Dec 17. Br J Cancer. 2014. PMID: 24346286 Free PMC article.

4

Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?

Lee JY, Lim SH, Kim M, Kim S, Jung HA, Chang WJ, Choi MK, Hong JY, Lee SJ, Sun JM, Ahn JS, Park K, Ahn MJ. Lee JY, et al. Among authors: jung ha. Cancer Chemother Pharmacol. 2014 May;73(5):1063-70. doi: 10.1007/s00280-014-2442-8. Epub 2014 Mar 25. Cancer Chemother Pharmacol. 2014. PMID: 24663503

5

Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease.

Choi MK, Hong JY, Chang W, Kim M, Kim S, Jung HA, Lee SJ, Park S, Chung MP, Sun JM, Park K, Ahn MJ, Ahn JS. Choi MK, et al. Among authors: jung ha. Cancer Chemother Pharmacol. 2014 Jun;73(6):1217-25. doi: 10.1007/s00280-014-2458-0. Epub 2014 Apr 3. Cancer Chemother Pharmacol. 2014. PMID: 24696125

6

Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series.

Kim SM, Kim MJ, Jung HA, Sun JM, Choi YL, Ko YH, Park K, Baek CH, Son YI, Ahn MJ. Kim SM, et al. Among authors: jung ha. Head Neck. 2015 May;37(5):E66-9. doi: 10.1002/hed.23884. Epub 2015 Mar 29. Head Neck. 2015. PMID: 25270523 Review.

7

Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology.

Jung HA, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH. Jung HA, et al. Tumour Biol. 2015 Feb;36(2):1073-9. doi: 10.1007/s13277-014-2730-2. Epub 2014 Oct 19. Tumour Biol. 2015. PMID: 25326808

8

High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.

Ku BM, Jung HA, Sun JM, Ko YH, Jeong HS, Son YI, Baek CH, Park K, Ahn MJ. Ku BM, et al. Among authors: jung ha. J Transl Med. 2014 Oct 25;12:299. doi: 10.1186/s12967-014-0299-6. J Transl Med. 2014. PMID: 25343854 Free PMC article.

9

Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal Cancer.

Jung HA, Sun JM, Park SH, Kwon GY, Lim HY. Jung HA, et al. Chemotherapy. 2014;60(2):73-80. doi: 10.1159/000368071. Epub 2014 Nov 29. Chemotherapy. 2014. PMID: 25471123

10

Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer.

Lee JY, Lim SH, Lee MY, Kim H, Kim M, Kim S, Jung HA, Sohn I, Gil WH, Lee JE, Kim SW, Nam SJ, Ahn JS, Im YH, Park YH. Lee JY, et al. Among authors: jung ha. Cancer Res Treat. 2015 Oct;47(4):765-73. doi: 10.4143/crt.2014.168. Epub 2015 Jan 13. Cancer Res Treat. 2015. PMID: 25622590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

473 results

Search Page